Legato Capital Management LLC reduced its holdings in shares of Innovex International, Inc. (NYSE:INVX – Free Report) by 25.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 98,829 shares of the company’s stock after selling 33,344 shares during the period. Legato Capital Management LLC’s holdings in Innovex International were worth $2,161,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Covestor Ltd increased its stake in Innovex International by 26,300.0% during the 3rd quarter. Covestor Ltd now owns 1,848 shares of the company’s stock worth $34,000 after buying an additional 1,841 shares during the period. Strs Ohio purchased a new stake in Innovex International during the 4th quarter worth approximately $44,000. Smartleaf Asset Management LLC increased its stake in Innovex International by 31.2% during the 3rd quarter. Smartleaf Asset Management LLC now owns 2,151 shares of the company’s stock worth $40,000 after buying an additional 511 shares during the period. Westfuller Advisors LLC purchased a new stake in Innovex International during the 3rd quarter worth approximately $53,000. Finally, Tower Research Capital LLC TRC increased its stake in Innovex International by 418.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,523 shares of the company’s stock worth $55,000 after buying an additional 2,843 shares during the period.
Insider Activity at Innovex International
In related news, Director Amberjack Capital Partners, L. sold 6,612,500 shares of the stock in a transaction on Friday, February 27th. The shares were sold at an average price of $24.59, for a total value of $162,601,375.00. Following the transaction, the director directly owned 399 shares of the company’s stock, valued at $9,811.41. This trade represents a 99.99% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Adam Anderson sold 18,837 shares of the stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $28.50, for a total transaction of $536,854.50. Following the completion of the transaction, the chief executive officer directly owned 466,744 shares in the company, valued at $13,302,204. This trade represents a 3.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 13,257,078 shares of company stock valued at $326,097,112 in the last ninety days. Insiders own 34.90% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on INVX
Innovex International Trading Down 2.7%
NYSE INVX opened at $30.00 on Friday. The company has a debt-to-equity ratio of 0.02, a current ratio of 5.10 and a quick ratio of 3.38. The firm’s fifty day moving average price is $26.40 and its 200 day moving average price is $24.63. The company has a market capitalization of $2.06 billion, a price-to-earnings ratio of 40.00 and a beta of 0.84. Innovex International, Inc. has a 12 month low of $13.44 and a 12 month high of $32.25.
Innovex International (NYSE:INVX – Get Free Report) last posted its earnings results on Monday, February 23rd. The company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.09). The company had revenue of $273.60 million during the quarter, compared to analysts’ expectations of $240.00 million. Innovex International had a net margin of 5.31% and a return on equity of 6.72%. On average, sell-side analysts expect that Innovex International, Inc. will post 1.44 earnings per share for the current fiscal year.
Innovex International Profile
Innovex International, Inc engages in the provision of solutions for both onshore and offshore applications within the oil and gas industry. The company was founded on September 15, 2016 and is headquartered in Humble, TX.
See Also
- Five stocks we like better than Innovex International
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Want to see what other hedge funds are holding INVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovex International, Inc. (NYSE:INVX – Free Report).
Receive News & Ratings for Innovex International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovex International and related companies with MarketBeat.com's FREE daily email newsletter.
